Medications for Geographic Atrophy
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Geographic Atrophy.
Found 2 Approved Drugs for Geographic Atrophy
Pegcetacoplan
Brand Names
Empaveli, Syfovre
Pegcetacoplan
Brand Names
Empaveli, Syfovre
Form: Injection
Method of administration: Subcutaneous, Intravitreal
FDA approval date: May 14, 2021
Classification: Complement Inhibitor
EMPAVELI™ is indicated for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH). EMPAVELI is a complement inhibitor indicated for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH). ( 1 )
Izervay
Generic Name
Avacincaptad Pegol
Izervay
Generic Name
Avacincaptad Pegol
Form: Injection
Method of administration: Intravitreal
FDA approval date: August 19, 2023
Classification: Complement Inhibitor
IZERVAY ™ is indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). IZERVAY is a complement inhibitor indicated for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD) ( 1 ).
Showing 1-2 of 2
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances